Ratio of Monocytes to Lymphocytes in Peripheral Blood Identifies Adults at Risk of Incident Tuberculosis Among HIV-Infected Adults Initiating Antiretroviral Therapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ratio of Monocytes to Lymphocytes in Peripheral Blood Identifies Adults at Risk of Incident Tuberculosis Among HIV-Infected Adults Initiating Antiretroviral Therapy
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 209, Issue 4, Pages 500-509
Publisher
Oxford University Press (OUP)
Online
2013-09-17
DOI
10.1093/infdis/jit494
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Ratio of Monocytes to Lymphocytes in Peripheral Blood Correlates with Increased Susceptibility to Clinical Malaria in Kenyan Children
- (2013) George M. Warimwe et al. PLoS One
- CD271+ Bone Marrow Mesenchymal Stem Cells May Provide a Niche for Dormant Mycobacterium tuberculosis
- (2013) B. Das et al. Science Translational Medicine
- Stem cell heterogeneity: implications for aging and regenerative medicine
- (2012) C. E. Muller-Sieburg et al. BLOOD
- Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
- (2012) David M. Tobin et al. CELL
- Sustainability of task-shifting for antiretroviral treatment
- (2012) Vivek Naranbhai et al. LANCET
- Latent tuberculosis: what the host “sees”?
- (2011) Hannah P. Gideon et al. IMMUNOLOGIC RESEARCH
- 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial
- (2011) Taraz Samandari et al. LANCET
- Tuberculosis
- (2011) Stephen D Lawn et al. LANCET
- Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis
- (2011) Molebogeng X Rangaka et al. LANCET INFECTIOUS DISEASES
- Integration of Antiretroviral Therapy with Tuberculosis Treatment
- (2011) Salim S. Abdool Karim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Primary Isoniazid Prophylaxis against Tuberculosis in HIV-Exposed Children
- (2011) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age
- (2011) W. W. Pang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hematopoietic Stem Cell Heterogeneity: Subtypes, Not Unpredictable Behavior
- (2010) Timm Schroeder Cell Stem Cell
- Human gene expression profiles of susceptibility and resistance in tuberculosis
- (2010) J Maertzdorf et al. GENES AND IMMUNITY
- Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources
- (2010) Stephen D Lawn et al. LANCET INFECTIOUS DISEASES
- Quiescent haematopoietic stem cells are activated by IFN-γ in response to chronic infection
- (2010) Megan T. Baldridge et al. NATURE
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
- (2010) Matthew P. R. Berry et al. NATURE
- Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
- (2010) Salim S. Abdool Karim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
- (2010) Q. Abdool Karim et al. SCIENCE
- The Prevalence and Drug Sensitivity of Tuberculosis among Patients Dying in Hospital in KwaZulu-Natal, South Africa: A Postmortem Study
- (2010) Ted Cohen et al. PLOS MEDICINE
- Establishing a Cohort at High Risk of HIV Infection in South Africa: Challenges and Experiences of the CAPRISA 002 Acute Infection Study
- (2008) Francois van Loggerenberg et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started